Jump to navigation
The ADAPT Study is exploring the impacts of COVID-19 on Australians who use illicit drugs.
NCETA is partnering with the Building Trades Group Drug and Alcohol Program to evaluate the Program’s AOD Impairment Awareness Training.
Researchers are interested in hearing about the experience and treatment preferences of individuals who suffer from chronic pain.
The newly established National Centre for Clinical Research on Emerging Drugs (NCCRED) has commissioned NCETA to conduct an audit of Australian met
NDRI is collaborating with Hello Sunday Morning on a research trial to evaluate the Daybreak mobile app.
NDRI’s evaluation of new take-home naloxone programs will inform the ongoing development of such programs in WA and elsewhere.
NDRI has been commissioned by South West Sydney Local Health District (SWSLHD) Drug Health Services (DHS) to conduct four research projects.
This project will provide an international literature review of the approaches taken in Ireland and other jurisdictions to simple possession drug offences.
This PhD project will examine the untreated remission of alcohol problems.
The world-first CESSATE Stop Smoking Study will compare two quitting aids (Desmoxan and Champix).
Over the past two years, NCETA and NADA have undertaken a comprehensive examination of the health and wellbeing of the non-government AOD workforce in NSW.
The national centres are supported by funding from the Australian Government under the Drug and Alcohol Program
Page last updated: Wednesday 20 May 2020